Theramex

A previous regulatory setback in the US for Kissei Pharmaceutical Co., Ltd ’s female health product linzagolix has not discouraged the Japanese firm from continued development of the oral gonadotropi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Helsinn Extends Akynzeo Marketing

Enzene Biosciences, a subsidiary of Alkem Laboratories Ltd , plans a regulatory filing in the US for a biosimilar to Amgen, Inc. ’s blockbuster osteoporosis drug Prolia (denosumab). Having tied up w

Despite missing out on a proposed acquisition priced at about four times its share price at the time of offer, TherapeuticsMD Inc. has found an exit for its shareholders by selling off its women’s h